About Us Services Careers FAQ Contact Us 0
Home Medical Devices Neurology Clinical Trials Market Growth Trends and Competitive Analysis 2030

Neurology Clinical Trials Market

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRMD2946DR
Study Period 2018-2030 CAGR 5.67%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD 5.01 Billion
Forecast Year 2030 Forecast Year Market Size USD 8.23 Billion
Largest Market North America Fastest Growing Market Middle East and Africa
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Neurology Clinical Trials Market, By Phase (2020-2030)
    1. Phase I
    2. Phase II
    3. Phase III
    4. Phase IV
  2. Neurology Clinical Trials Market, By Study Design (2020-2030)
    1. Interventional
    2. Observational
    3. Expanded Access
  3. Neurology Clinical Trials Market, By Indication (2020-2030)
    1. Epilepsy
    2. Parkinson's Disease (PD)
    3. Huntington's Disease
    4. Stroke
    5. Traumatic Brain Injury (TBI)
    6. Amyotrophic Lateral Sclerosis (ALS)
    7. Muscle regeneration
    8. Others
    1. North America
      1. North America Neurology Clinical Trials Market, By Phase
        1. Phase I
          1. Phase II
            1. Phase III
              1. Phase IV
              2. North America Neurology Clinical Trials Market, By Study Design
                1. Interventional
                  1. Observational
                    1. Expanded Access
                    2. North America Neurology Clinical Trials Market, By Indication
                      1. Epilepsy
                        1. Parkinson's Disease (PD)
                          1. Huntington's Disease
                            1. Stroke
                              1. Traumatic Brain Injury (TBI)
                                1. Amyotrophic Lateral Sclerosis (ALS)
                                  1. Muscle regeneration
                                    1. Others
                                    2. U.S.
                                      1. U.S. Neurology Clinical Trials Market, By Phase
                                        1. Phase I
                                          1. Phase II
                                            1. Phase III
                                              1. Phase IV
                                              2. U.S. Neurology Clinical Trials Market, By Study Design
                                                1. Interventional
                                                  1. Observational
                                                    1. Expanded Access
                                                    2. U.S. Neurology Clinical Trials Market, By Indication
                                                      1. Epilepsy
                                                        1. Parkinson's Disease (PD)
                                                          1. Huntington's Disease
                                                            1. Stroke
                                                              1. Traumatic Brain Injury (TBI)
                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                  1. Muscle regeneration
                                                                    1. Others
                                                                  2. Canada
                                                                2. Europe
                                                                  1. Europe Neurology Clinical Trials Market, By Phase
                                                                    1. Phase I
                                                                      1. Phase II
                                                                        1. Phase III
                                                                          1. Phase IV
                                                                          2. Europe Neurology Clinical Trials Market, By Study Design
                                                                            1. Interventional
                                                                              1. Observational
                                                                                1. Expanded Access
                                                                                2. Europe Neurology Clinical Trials Market, By Indication
                                                                                  1. Epilepsy
                                                                                    1. Parkinson's Disease (PD)
                                                                                      1. Huntington's Disease
                                                                                        1. Stroke
                                                                                          1. Traumatic Brain Injury (TBI)
                                                                                            1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                              1. Muscle regeneration
                                                                                                1. Others
                                                                                                2. U.K.
                                                                                                  1. U.K. Neurology Clinical Trials Market, By Phase
                                                                                                    1. Phase I
                                                                                                      1. Phase II
                                                                                                        1. Phase III
                                                                                                          1. Phase IV
                                                                                                          2. U.K. Neurology Clinical Trials Market, By Study Design
                                                                                                            1. Interventional
                                                                                                              1. Observational
                                                                                                                1. Expanded Access
                                                                                                                2. U.K. Neurology Clinical Trials Market, By Indication
                                                                                                                  1. Epilepsy
                                                                                                                    1. Parkinson's Disease (PD)
                                                                                                                      1. Huntington's Disease
                                                                                                                        1. Stroke
                                                                                                                          1. Traumatic Brain Injury (TBI)
                                                                                                                            1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                              1. Muscle regeneration
                                                                                                                                1. Others
                                                                                                                              2. Germany
                                                                                                                              3. France
                                                                                                                              4. Spain
                                                                                                                              5. Italy
                                                                                                                              6. Russia
                                                                                                                              7. Nordic
                                                                                                                              8. Benelux
                                                                                                                              9. Rest of Europe
                                                                                                                            2. APAC
                                                                                                                              1. APAC Neurology Clinical Trials Market, By Phase
                                                                                                                                1. Phase I
                                                                                                                                  1. Phase II
                                                                                                                                    1. Phase III
                                                                                                                                      1. Phase IV
                                                                                                                                      2. APAC Neurology Clinical Trials Market, By Study Design
                                                                                                                                        1. Interventional
                                                                                                                                          1. Observational
                                                                                                                                            1. Expanded Access
                                                                                                                                            2. APAC Neurology Clinical Trials Market, By Indication
                                                                                                                                              1. Epilepsy
                                                                                                                                                1. Parkinson's Disease (PD)
                                                                                                                                                  1. Huntington's Disease
                                                                                                                                                    1. Stroke
                                                                                                                                                      1. Traumatic Brain Injury (TBI)
                                                                                                                                                        1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                          1. Muscle regeneration
                                                                                                                                                            1. Others
                                                                                                                                                            2. China
                                                                                                                                                              1. China Neurology Clinical Trials Market, By Phase
                                                                                                                                                                1. Phase I
                                                                                                                                                                  1. Phase II
                                                                                                                                                                    1. Phase III
                                                                                                                                                                      1. Phase IV
                                                                                                                                                                      2. China Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                        1. Interventional
                                                                                                                                                                          1. Observational
                                                                                                                                                                            1. Expanded Access
                                                                                                                                                                            2. China Neurology Clinical Trials Market, By Indication
                                                                                                                                                                              1. Epilepsy
                                                                                                                                                                                1. Parkinson's Disease (PD)
                                                                                                                                                                                  1. Huntington's Disease
                                                                                                                                                                                    1. Stroke
                                                                                                                                                                                      1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                        1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                          1. Muscle regeneration
                                                                                                                                                                                            1. Others
                                                                                                                                                                                          2. Korea
                                                                                                                                                                                          3. Japan
                                                                                                                                                                                          4. India
                                                                                                                                                                                          5. Australia
                                                                                                                                                                                          6. Taiwan
                                                                                                                                                                                          7. South East Asia
                                                                                                                                                                                          8. Rest of Asia-Pacific
                                                                                                                                                                                        2. Middle East and Africa
                                                                                                                                                                                          1. Middle East and Africa Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                            1. Phase I
                                                                                                                                                                                              1. Phase II
                                                                                                                                                                                                1. Phase III
                                                                                                                                                                                                  1. Phase IV
                                                                                                                                                                                                  2. Middle East and Africa Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                    1. Interventional
                                                                                                                                                                                                      1. Observational
                                                                                                                                                                                                        1. Expanded Access
                                                                                                                                                                                                        2. Middle East and Africa Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                          1. Epilepsy
                                                                                                                                                                                                            1. Parkinson's Disease (PD)
                                                                                                                                                                                                              1. Huntington's Disease
                                                                                                                                                                                                                1. Stroke
                                                                                                                                                                                                                  1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                    1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                      1. Muscle regeneration
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                        2. UAE
                                                                                                                                                                                                                          1. UAE Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                            1. Phase I
                                                                                                                                                                                                                              1. Phase II
                                                                                                                                                                                                                                1. Phase III
                                                                                                                                                                                                                                  1. Phase IV
                                                                                                                                                                                                                                  2. UAE Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                    1. Interventional
                                                                                                                                                                                                                                      1. Observational
                                                                                                                                                                                                                                        1. Expanded Access
                                                                                                                                                                                                                                        2. UAE Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                          1. Epilepsy
                                                                                                                                                                                                                                            1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                              1. Huntington's Disease
                                                                                                                                                                                                                                                1. Stroke
                                                                                                                                                                                                                                                  1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                    1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                      1. Muscle regeneration
                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                      1. LATAM Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                                                        1. Phase I
                                                                                                                                                                                                                                                          1. Phase II
                                                                                                                                                                                                                                                            1. Phase III
                                                                                                                                                                                                                                                              1. Phase IV
                                                                                                                                                                                                                                                              2. LATAM Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                                                1. Interventional
                                                                                                                                                                                                                                                                  1. Observational
                                                                                                                                                                                                                                                                    1. Expanded Access
                                                                                                                                                                                                                                                                    2. LATAM Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                                                      1. Epilepsy
                                                                                                                                                                                                                                                                        1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                                                          1. Huntington's Disease
                                                                                                                                                                                                                                                                            1. Stroke
                                                                                                                                                                                                                                                                              1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                                                  1. Muscle regeneration
                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                    2. Brazil
                                                                                                                                                                                                                                                                                      1. Brazil Neurology Clinical Trials Market, By Phase
                                                                                                                                                                                                                                                                                        1. Phase I
                                                                                                                                                                                                                                                                                          1. Phase II
                                                                                                                                                                                                                                                                                            1. Phase III
                                                                                                                                                                                                                                                                                              1. Phase IV
                                                                                                                                                                                                                                                                                              2. Brazil Neurology Clinical Trials Market, By Study Design
                                                                                                                                                                                                                                                                                                1. Interventional
                                                                                                                                                                                                                                                                                                  1. Observational
                                                                                                                                                                                                                                                                                                    1. Expanded Access
                                                                                                                                                                                                                                                                                                    2. Brazil Neurology Clinical Trials Market, By Indication
                                                                                                                                                                                                                                                                                                      1. Epilepsy
                                                                                                                                                                                                                                                                                                        1. Parkinson's Disease (PD)
                                                                                                                                                                                                                                                                                                          1. Huntington's Disease
                                                                                                                                                                                                                                                                                                            1. Stroke
                                                                                                                                                                                                                                                                                                              1. Traumatic Brain Injury (TBI)
                                                                                                                                                                                                                                                                                                                1. Amyotrophic Lateral Sclerosis (ALS)
                                                                                                                                                                                                                                                                                                                  1. Muscle regeneration
                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                                                                                                              Related Reports

                                                                                                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                                                                                                              The global pediatric clinical trials market size was valued at USD 14.33 billion in 2021 and is predicted to reach at USD 22.69 billion by 2030, increasing at a CAGR of 5.24% from 2022 to 2030. For a variety of indications that affect children, paed
                                                                                                                                                                                                                                                                                                              Buy Now

                                                                                                                                                                                                                                                                                                              Purchase Benefits

                                                                                                                                                                                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                              • Completely customizable scope
                                                                                                                                                                                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                              • Dedicated account manager
                                                                                                                                                                                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                              • Permission to print the report

                                                                                                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                                                                                                              www.straitsresearch.com
                                                                                                                                                                                                                                                                                                              © Copyright . All rights Reserved.